Patrys Share Price and Company Fundamentals
Last traded: Today at 4:45 AM
Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates cell nuclei and inhibits mechanisms of DNA repair in target cancer cells. The company also focuses on developing PAT-DX1, an antibody fragment for the treatment of primary and secondary brain cancer, triple negative breast cancer, and glioblastoma. In addition, it is developing PAT-DX3, a full-sized antibody that has DNA-binding and DNA damage repair blocking properties of PAT-DX1 used for tissue distribution, pharmacokinetic profile, etc.; and PAT-DX1-NP, a product based on the targeted delivery of nanoparticles carrying therapeutic payloads to the inside of cancer cells. Patrys Limited has a collaborative research program with Imagion Biosystems Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis. The company was incorporated in 2006 and is based in Melbourne, Australia.
|Primary activities||Development of natural human antibody-based therapies for the treatment of life threatening diseases including cancer.|
|Industry / Sector||Biotechnology / Healthcare|
|Mailing address||100 Albert Road Level 4 Melbourne VIC 3205 Australia|
|Phone / Fax||61 3 9670 3273 / 61 3 9077 9233|
|Share registry||COMPUTERSHARE INVESTOR SERVICES PTY LIMITED|
Patrys does not pay dividends.
As of Jan 2022, following are the company executives and directors listed on Patrys.
|Dr. James A. Campbell B.Sc., MBA, Ph.D.||MD, CEO & Exec. Director||528.7k|
|Dr. Deanne Greenwood B.Sc., GAICD, MBA, Ph.D.||VP of Bus. Devel. & Intellectual Property|
|Mr. Stefan Ross||Company Sec.|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Patrys is and its enterprise value is .
Companies similar to Patrys (PAB)
Patrys (ASX:PAB) Frequently Asked Questions
1. What is Patrys's Stock Symbol?
Patrys trades on ASX under the ticker symbol "PAB".
2. What is Patrys's stock price today?
One share of PAB stock can currently be purchased for approximately $0.038.
3. How can I contact Patrys?
Patrys's mailing address is 100 Albert Road Level 4 Melbourne VIC 3205 Australia. The company can be reached via phone at 61 3 9670 3273.
4. What is Patrys's official website?
The official website of Patrys is https://www.patrys.com.
5. Which share registry manages Patrys's stock?
Patrys's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.